Mice received subcutaneous (s.c.) injections of G49 (20500 nmol/kg) or vehicle (50 mM sodium phosphate, 300 mM mannitol, pH 6.9) or Fc-GLP1 (50 nmol/kg) or vehicle (saline) every 2 days for the indicated time-periods up to 1 week
These steps boost muscle, brain function, and overall health, including better metabolism and sleep
Two weeks after initiation of the antibiotics, we administered a single subcutaneous injection of liraglutide or saline to the mice
The Orforglipron segment is the fastest-growing in the oral GLP-1 market due to its innovative small-molecule, non-peptide oral formulation, which eliminates the need for injections and enhances patient convenience
Jabbarpoor Bonyadi MH, Yazdani S, Saadat S
However, these drugs do not come without side effects